Clinical Trial Update: Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating glucose-lowering effects and safety of adding 0.25 or 0.5 mg Duvie in adults with Type 2 Diabetes Mellitus and inadequate glucos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Duvie (Duvie)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Type 2 Diabetes Mellitus, Inadequate Glucose Control | Phase 4 | Status: COMPLETED